Albumin & Creatinine Tests Market - Trends Forecast Till 2028

Albumin & Creatinine Tests Market, by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs)

Published Date: January, 2021

Base Year Estimate: 2020

Report ID: D-HC-ACTM-75

Format:  

Number of Pages: 235

Domain: Healthcare

Albumin & Creatinine Tests Market – Trends Forecast Till 2028

The global Albumin & Creatinine Tests market is anticipated to reach USD 990 million by 2021 and growing at a CAGR of 16.5% during the forecasting period, 2021-2028.

The growth of the global albumin & creatinine tests market is driven by the growing prevalence of kidney disorders/diseases, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions. Kidney disease is one of the leading causes of death across the globe. Such cases—involving multiple kidney treatments—require the regular monitoring of components like creatinine and albumin and their ratios, for which multiple urine analysis products and techniques are used.

A challenge for this market is that most small hospitals and clinics with lower workloads still prefer semi-automated devices or manual analysis. Automated devices are primarily used by large hospitals with higher workloads; thus, the revenue generation can justify the costs incurred in installing automated analyzers. 

Albumin & Creatinine Tests Market – Trends Forecast Till 2028

Global Albumin & Creatinine Tests market is segmented into Product, Type, End-User, 

Product segment is segmented into Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits and Reagents

Type segment is segmented into Blood & Urine Creatinine, Urine Albumin, and Glycated Albumin

End-user segment is segmented into Hospital, Diagnostic & Research Labs

Geographically, the global Albumin & Creatinine Tests market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Key players in the global Albumin & Creatinine Tests market are Roche Diagnostics, Abbott Laboratories, and Danaher Corporation.

The companies have come up with various promotional activities in the form of launch, investment, acquisition, and other, for instance:

  • Over 130 Abbott scientists conduct research and development to meet the specific needs of various countries. These scientists work passionately to advance health by addressing the country’s unique challenges. Some of our contributions include developing locally relevant nutrition products for women, children, and diabetic patients; treating epilepsy in children; raising awareness of thyroid conditions; combating gingivitis, and more.

Available Customizations

In addition to the market data for Albumin & Creatinine Tests market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, conferences like Jefferies conference)—to identify and collect information useful for this study of the Albumin & Creatinine Tests market. The purpose of secondary research is to identify and collection of extensive, technical, market-oriented, and commercial studies of the global Albumin & Creatinine Tests market. Through secondary research, the market is classified and segmented as per industry trends, developments, regional markets, products, and technological developments. 

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the Albumin & Creatinine Tests market.

Primary Respondent breakdown is given below:

Primary Respondents

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the Albumin & Creatinine Tests market. This approach has also been used to derive the market for segmentation and sub-segmentation. 

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data, we contact primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants 

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for Albumin & Creatinine Tests market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 990 Million

Growth Rate

CAGR of 16.5% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year 

2020

Units Considered

Revenue in USD million and CAGR from 2021 to 2028

Report Segmentation

Product, Type, End-user and 

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

 U.S., Roche Diagnostics, Abbott Laboratories, and Danaher Corporation

Available Customization 

In addition to the market data for Albumin & Creatinine Tests market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.